Annual CFO
-$292.37 M
-$104.21 M-55.38%
December 31, 2024
Summary
- As of March 14, 2025, DYN annual cash flow from operations is -$292.37 million, with the most recent change of -$104.21 million (-55.38%) on December 31, 2024.
- During the last 3 years, DYN annual CFO has fallen by -$172.81 million (-144.53%).
- DYN annual CFO is now -6921.35% below its all-time high of -$4.16 million, reached on December 31, 2018.
Performance
DYN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$84.33 M
-$9.71 M-13.01%
December 31, 2024
Summary
- As of March 14, 2025, DYN quarterly cash flow from operations is -$84.33 million, with the most recent change of -$9.71 million (-13.01%) on December 31, 2024.
- Over the past year, DYN quarterly CFO has dropped by -$29.47 million (-53.71%).
- DYN quarterly CFO is now -1057.18% below its all-time high of -$7.29 million, reached on March 31, 2020.
Performance
DYN Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$292.37 M
-$49.33 M-20.30%
December 31, 2024
Summary
- As of March 14, 2025, DYN TTM cash flow from operations is -$292.37 million, with the most recent change of -$49.33 million (-20.30%) on December 31, 2024.
- Over the past year, DYN TTM CFO has dropped by -$73.36 million (-33.49%).
- DYN TTM CFO is now -3911.65% below its all-time high of -$7.29 million, reached on March 31, 2020.
Performance
DYN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
DYN Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -55.4% | -53.7% | -33.5% |
| 3 y3 years | -144.5% | -51.6% | -67.5% |
| 5 y5 years | -2370.6% | -51.6% | -67.5% |
DYN Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -144.5% | at low | -200.5% | at low | -144.5% | at low |
| 5 y | 5-year | -2370.6% | at low | -1057.2% | at low | -3911.7% | at low |
| alltime | all time | -6921.4% | at low | -1057.2% | at low | -3911.7% | at low |
Dyne Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$292.37 M(+55.4%) | -$84.33 M(+13.0%) | -$292.37 M(+20.3%) |
| Sep 2024 | - | -$74.63 M(+36.0%) | -$243.04 M(+11.0%) |
| Jun 2024 | - | -$54.87 M(-30.1%) | -$219.01 M(-0.4%) |
| Mar 2024 | - | -$78.54 M(+124.4%) | -$219.79 M(+16.8%) |
| Dec 2023 | -$188.16 M(+22.5%) | -$35.01 M(-30.8%) | -$188.16 M(+3.2%) |
| Sep 2023 | - | -$50.60 M(-9.1%) | -$182.34 M(+4.5%) |
| Jun 2023 | - | -$55.64 M(+18.6%) | -$174.55 M(+16.5%) |
| Mar 2023 | - | -$46.91 M(+60.7%) | -$149.81 M(-2.5%) |
| Dec 2022 | -$153.65 M | -$29.19 M(-31.8%) | -$153.65 M(+0.7%) |
| Sep 2022 | - | -$42.80 M(+38.5%) | -$152.52 M(+11.6%) |
| Jun 2022 | - | -$30.91 M(-39.1%) | -$136.67 M(-10.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$50.74 M(+80.8%) | -$151.91 M(+27.1%) |
| Dec 2021 | -$119.56 M(+157.1%) | -$28.07 M(+4.1%) | -$119.56 M(+7.2%) |
| Sep 2021 | - | -$26.95 M(-41.6%) | -$111.53 M(+15.6%) |
| Jun 2021 | - | -$46.15 M(+150.9%) | -$96.47 M(+67.4%) |
| Mar 2021 | - | -$18.39 M(-8.2%) | -$57.61 M(+23.9%) |
| Dec 2020 | -$46.51 M(+293.0%) | -$20.04 M(+68.6%) | -$46.51 M(+75.7%) |
| Sep 2020 | - | -$11.89 M(+62.9%) | -$26.47 M(+81.5%) |
| Jun 2020 | - | -$7.30 M(+0.1%) | -$14.59 M(+100.1%) |
| Mar 2020 | - | -$7.29 M | -$7.29 M |
| Dec 2019 | -$11.83 M(+184.2%) | - | - |
| Dec 2018 | -$4.16 M | - | - |
FAQ
- What is Dyne Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Dyne Therapeutics?
- What is Dyne Therapeutics annual CFO year-on-year change?
- What is Dyne Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Dyne Therapeutics?
- What is Dyne Therapeutics quarterly CFO year-on-year change?
- What is Dyne Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Dyne Therapeutics?
- What is Dyne Therapeutics TTM CFO year-on-year change?
What is Dyne Therapeutics annual cash flow from operations?
The current annual CFO of DYN is -$292.37 M
What is the all time high annual CFO for Dyne Therapeutics?
Dyne Therapeutics all-time high annual cash flow from operations is -$4.16 M
What is Dyne Therapeutics annual CFO year-on-year change?
Over the past year, DYN annual cash flow from operations has changed by -$104.21 M (-55.38%)
What is Dyne Therapeutics quarterly cash flow from operations?
The current quarterly CFO of DYN is -$84.33 M
What is the all time high quarterly CFO for Dyne Therapeutics?
Dyne Therapeutics all-time high quarterly cash flow from operations is -$7.29 M
What is Dyne Therapeutics quarterly CFO year-on-year change?
Over the past year, DYN quarterly cash flow from operations has changed by -$29.47 M (-53.71%)
What is Dyne Therapeutics TTM cash flow from operations?
The current TTM CFO of DYN is -$292.37 M
What is the all time high TTM CFO for Dyne Therapeutics?
Dyne Therapeutics all-time high TTM cash flow from operations is -$7.29 M
What is Dyne Therapeutics TTM CFO year-on-year change?
Over the past year, DYN TTM cash flow from operations has changed by -$73.36 M (-33.49%)